Brick & Kyle Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Brick & Kyle Associates's LLY Position: Q2 2026 in Review
Brick & Kyle Associates held its Eli Lilly (LLY) position steady in Q2 2026 at 3,972 shares worth $3.65M. The position accounts for 1.21% of the portfolio, ranked #30.
Brick & Kyle Associates first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.8M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Brick & Kyle Associates held 3,972 shares of Eli Lilly worth $3.65M as of Q2 2026.
- Brick & Kyle Associates left its Eli Lilly share count unchanged in Q2 2026.
- Eli Lilly made up 1.21% of Brick & Kyle Associates's portfolio in Q2 2026, its #30 holding.
- Brick & Kyle Associates first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- Brick & Kyle Associates's Eli Lilly position peaked at $4.8M in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Brick & Kyle Associates's 13F filing for Q2 2026, filed 6 Aug 2026.